Leonteq Securities’s Tarsus Pharmaceuticals TARS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$157K Hold
2,000
– – 0.01% 559
2026
Q2
$126K Hold
2,000
– – ﹤0.01% 655
2026
Q1
$140K Hold
2,000
– – 0.01% 669
2025
Q4
$164K Sell
2,000
-4,500
-69% -$336K 0.01% 705
2025
Q3
$386K Buy
+6,500
New +$320K 0.01% 458

Other funds holding TARS

Leonteq Securities's TARS Position: Q3 2026 in Review

Leonteq Securities held its Tarsus Pharmaceuticals (TARS) position steady in Q3 2026 at 2,000 shares worth $157K. The position accounts for 0.01% of the portfolio, ranked #559.

Leonteq Securities first reported a position in TARS in Q3 2025 and has held it in 5 quarters since. The position peaked at $386K in Q3 2025. 247 funds tracked by Wall St. Rank hold TARS as of Q3 2026.

  • Leonteq Securities held 2,000 shares of Tarsus Pharmaceuticals worth $157K as of Q3 2026.
  • Leonteq Securities left its Tarsus Pharmaceuticals share count unchanged in Q3 2026.
  • Tarsus Pharmaceuticals made up 0.01% of Leonteq Securities's portfolio in Q3 2026, its #559 holding.
  • Leonteq Securities first reported a position in Tarsus Pharmaceuticals in Q3 2025 and has held it in 5 quarters since.
  • Leonteq Securities's Tarsus Pharmaceuticals position peaked at $386K in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q3 2026.

Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.